Figure 2: Cytokine expression profiles of pDCs treated with low or high doses of CpG or GpC.
From: High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway

(a) Il6, Il10, Il23a, Ifna1, Ifnb1, Ifng and Tgfb1 transcripts were evaluated in pDCs treated with 1 or 10 μg ml−1 of CpG, nc-ODN or GpC for 6 h. IL-6, IL-10, IL-23 p19, IFN-α, IFN-β, IFN-γ and TGF-β mRNAs were quantified by real-time PCR using Gapdh normalization. Data (means±s.d. from four experiments) are presented as transcriptional expression of the different cytokines relative to basal cytokine transcript amount in unstimulated cells. *P<0.005; Student’s t-test. (b) pDCs were assayed for cytokine release after CpG, nc-ODN or GpC exposure. Data are means±s.d. from four experiments. (c) Intracellular TGF-β staining profiles of B220+ pDCs treated with 1 or 10 μg ml−1 of CpG for 24 h. Shown in upper right quadrants are percentages of double-positive cells. One experiment is shown representative of six, all of which are visualized by scatter plot in Supplementary Fig. S6. (d) Production of TGF-β by pDCs untreated or treated with 1 (pDC/L-CpG) or 10 (pDC/H-CpG) μg ml−1 of ODN. Supernatants were harvested at 72 h after stimulation and assayed for active TGF-β. *P<0.01; Student’s t-test.